GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...

Health Canada begins a priority review of semaglutide 2.4 mg, a weekly treatment by Novo Nordisk for MASH, a liver disease ...

Reddit just delivered the kind of quarter Wall Street couldn't ignore. Revenue for Q1 surged 61% to $392.4 million, well ...